Ondansetrón B. Braun (Ondansetron)

Ondansetron, the active ingredient in Ondansetrón B. Braun, is a 5-HT3 receptor antagonist presented as an intravenous solution for IV use. It is employed to prevent nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery in adult and pediatric patients. GNH USA supplies Ondansetrón B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetrón B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Ondansetron is used to manage nausea and vomiting by acting on the serotonergic pathways involved in emesis.

- Chemotherapy‑induced nausea and vomiting: helps prevent and control acute and delayed episodes. - Radiotherapy‑induced nausea and vomiting: reduces the frequency and severity of symptoms. - Post‑operative nausea and vomiting: decreases the incidence of nausea and vomiting after surgery. - Pregnancy‑related nausea (hyperemesis gravidarum): used when other treatments are ineffective, under specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist  … - Post‑operative  …  … … … … … … … … … … … …

Common  …  …